Imagion Biosystems Limited ASX: IBX Imagion Biosystems Limited ASX: IBX ACN 616 305 027 Suite 2, Level 11 385 Bourke Street Melbourne VIC 3000 imagionbiosystems.com | investor@imagionbio.com A S X A N N O U N C E M E N T | 2 8 J U L Y 2 0 2 6 Non-Dilutive Short-Term Funding...
Non-Dilutive Short-Term Funding Secured
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Earlier from Imagion Biosystems
- Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial
- IBX Secures Firm Commitments for $3.75m for Clinical Trial
- Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
- Imagion Biosystems Receives IND Clearance from US FDA
- Appendix 4C and Quarterly Activities Report - March 2026
Later from Imagion Biosystems
- Proposed issue of securities - IBX
- Appendix 4C and Quarterly Activities Report - June 2026
- Results of General Meeting
- Application for quotation of securities - IBX
- Cleansing Notice
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems